Elevance Health Inc. (ANTM)

Elevance Health Inc. (ANTM) Healthcare & Pipeline Overview

Elevance Health Inc. (ANTM) is a major U.S. health benefits provider, offering managed care plans to diverse markets, including large and small groups, individuals, and government programs like Medicaid and Medicare. With a focus on network-based solutions and specialty services, Elevance Health serves over 45 million medical members.

What Is the Investment Thesis for ANTM?

Elevance Health presents a compelling investment case based on its established market position and diversified revenue streams. The company's extensive network of 45 million medical members provides a stable base for continued growth. Key value drivers include the expansion of its Government Business segment, particularly within Medicaid and Medicare, and the growth of IngenioRx, its pharmacy benefits management arm. The company's P/E ratio of 16.5 suggests a potentially undervalued stock relative to its earnings. Upcoming catalysts include further penetration into underserved markets and strategic partnerships to expand its service offerings. Potential risks include regulatory changes in the healthcare industry and increasing competition from other major health insurers.

Based on FMP financials and quantitative analysis

ANTM Key Highlights

• Elevance Health serves 45 million medical members as of December 31, 2021, demonstrating a substantial market presence.
• The company operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other, diversifying its revenue streams.
• Elevance Health offers a dividend yield of 2.32%, providing a steady income stream for investors.
• The company's beta of 0.97 indicates lower volatility compared to the overall market.
• Elevance Health has a gross margin of 25.6%, reflecting its ability to manage costs effectively.

Who Are ANTM's Competitors?

ANTM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ANTM's Key Strengths?

• Large membership base of 45 million.
• Diversified business segments including Commercial, Government, and IngenioRx.
• Strong brand recognition through Blue Cross and Blue Shield affiliation.
• Experienced management team.

What Are ANTM's Weaknesses?

• Exposure to regulatory changes in the healthcare industry.
• Dependence on government funding for Medicaid and Medicare programs.
• Competition from other large health insurers.
• Potential for rising healthcare costs to impact profitability.

What Could Drive ANTM Stock Higher?

• Expansion of Medicaid and Medicare contracts in new states.
• Growth of IngenioRx pharmacy benefits management services.
• Implementation of value-based care models to improve health outcomes and reduce costs.
• Launch of new personalized healthcare solutions leveraging data analytics.

What Are the Key Risks for ANTM?

• Regulatory changes impacting the Affordable Care Act and other healthcare laws.
• Increasing competition from other large health insurers.
• Rising healthcare costs impacting profitability.
• Economic downturn leading to membership declines.
• Cyber security breaches impacting member data.

What Are the Growth Opportunities for ANTM?

• Expansion of Government Business: Elevance Health has a significant opportunity to grow its Government Business segment by increasing its participation in Medicaid and Medicare programs. As government-sponsored healthcare programs continue to expand, Elevance Health can leverage its expertise and infrastructure to capture a larger share of this market. This includes offering specialized plans tailored to the needs of low-income individuals and seniors, potentially increasing membership by 10% over the next 3 years.
• Growth of IngenioRx: Elevance Health's pharmacy benefits management (PBM) arm, IngenioRx, presents a substantial growth opportunity. By expanding its PBM services to other health plans and employers, IngenioRx can increase its revenue and profitability. This includes leveraging data analytics to optimize drug formularies and negotiate favorable pricing with pharmaceutical manufacturers. The PBM market is projected to reach $600 billion by 2028, offering significant upside for IngenioRx.
• Strategic Partnerships and Acquisitions: Elevance Health can pursue strategic partnerships and acquisitions to expand its service offerings and geographic reach. This includes partnering with healthcare technology companies to offer innovative digital health solutions and acquiring smaller health plans to enter new markets. These initiatives could add 5-7% to revenue growth annually.
• Focus on Value-Based Care: Elevance Health can further enhance its competitive advantage by focusing on value-based care models. This involves shifting from fee-for-service to reimbursement models that reward quality and outcomes. By partnering with providers to improve care coordination and reduce unnecessary costs, Elevance Health can improve the health of its members and lower healthcare expenses. This can improve profitability by 1-2% annually.
• Personalized Healthcare Solutions: Elevance Health can leverage data analytics and artificial intelligence to offer personalized healthcare solutions to its members. This includes providing tailored recommendations for preventive care, disease management, and lifestyle modifications. By engaging members with personalized interventions, Elevance Health can improve health outcomes and reduce healthcare costs. The personalized healthcare market is expected to grow to $1 trillion by 2030.

What Opportunities Does ANTM Have?

• Expansion into new geographic markets.
• Growth of value-based care models.
• Development of personalized healthcare solutions.
• Strategic partnerships and acquisitions.

What Threats Does ANTM Face?

• Increasing competition from other health insurers.
• Adverse regulatory changes.
• Rising healthcare costs.
• Economic downturn impacting membership.

What Are ANTM's Competitive Advantages?

• Scale: Elevance Health's large membership base of 45 million provides economies of scale in negotiating with providers and managing healthcare costs.
• Network Effects: The company's extensive provider network attracts more members, creating a virtuous cycle.
• Brand Recognition: Elevance Health operates as a licensee of the Blue Cross and Blue Shield Association, leveraging a well-known and trusted brand.
• Regulatory Expertise: The company has deep expertise in navigating the complex regulatory landscape of the healthcare industry.

What Does ANTM Do?

Founded in 1944 and headquartered in Indianapolis, Indiana, Elevance Health Inc., formerly known as WellPoint, Inc., has evolved into one of the largest health benefits companies in the United States. The company operates through four primary segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. Elevance Health provides a wide array of network-based managed care health benefit plans, including preferred provider organizations (PPOs), health maintenance organizations (HMOs), and point-of-service (POS) plans. These plans cater to various customer segments, including large and small groups, individuals, and those enrolled in Medicaid and Medicare programs. Beyond traditional health plans, Elevance Health offers consumer-driven health plans, hospital-only products, and limited benefit products. The company also delivers managed care services to self-funded customers, encompassing claims processing, underwriting, stop-loss insurance, actuarial services, provider network access, and medical management. Its specialty services include pharmacy benefits management (PBM) through IngenioRx, dental, vision, life, and disability insurance benefits. Elevance Health further extends its reach by providing services to the federal government via the Federal Employee Program and operating as a Blue Cross and Blue Shield Association licensee. As of December 31, 2021, Elevance Health served approximately 45 million medical members through its affiliated health plans, solidifying its position as a key player in the U.S. healthcare landscape.

What Products and Services Does ANTM Offer?

• Provides managed care health benefit plans to large and small groups.
• Offers health maintenance organizations (HMOs) and preferred provider organizations (PPOs).
• Administers point-of-service (POS) plans and traditional indemnity plans.
• Provides consumer-driven health plans and hospital-only products.
• Offers pharmacy benefits management (PBM) services through IngenioRx.
• Provides dental, vision, life, and disability insurance benefits.
• Offers services to the federal government via the Federal Employee Program.
• Operates as a licensee of the Blue Cross and Blue Shield Association.

How Does ANTM Make Money?

• Generates revenue through premiums paid by members for health insurance coverage.
• Earns fees for providing administrative services to self-funded customers.
• Profits from managing pharmacy benefits through IngenioRx.
• Receives payments from the government for administering Medicaid and Medicare plans.

What Industry Does ANTM Operate In?

Elevance Health operates within the dynamic and highly regulated healthcare industry. The market for health insurance plans is characterized by increasing demand driven by an aging population and rising healthcare costs. The industry is also subject to ongoing regulatory changes, including those related to the Affordable Care Act and Medicare/Medicaid programs. Elevance Health competes with other major players in the managed care space, such as COR, CPYT, DFHL, GTS, and HRAA, all vying for market share in a landscape marked by consolidation and innovation.

Who Are ANTM's Key Customers?

• Large and small employer groups seeking health benefits for their employees.
• Individuals and families purchasing health insurance plans.
• Medicaid and Medicare beneficiaries.
• Self-funded employers outsourcing administrative services.

Net sellingInsider Activity

The most recent 12 insider filings for Elevance Health Inc. break down as 4 sales and 8 purchases. On net that is roughly 411 shares disposed (about $929K), a signal worth weighing alongside the fundamentals.

F-Score 6/9Financial Health

Elevance Health Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.17 places it in the safe zone, indicating low near-term bankruptcy risk.

ROE 12%Key Financial Metrics

Return on equity for Elevance Health Inc. stands at 12.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.2%, showing how much profit it generates from its asset base. ANTM trades at a trailing price-to-earnings ratio of 16.54, below the Healthcare sector average of ~23x. Its free cash flow yield is 7.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.48 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.0%, the inverse of the P/E and a quick read on earnings relative to price.

Elevance Health Inc. (ANTM) Valuation Context

Valued at $114.59B, ANTM is classified as a large-cap stock. Relative to its peer group, ANTM's quantitative score of 48/100 is roughly in line with the peer average of 54/100.

ANTM Revenue & Earnings Trend

In Q1 2026, ANTM generated $50.18B in top-line revenue, marking a sequential increase of 0.9%. The company recorded net income of $1.76B, with diluted EPS of $220.40. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Healthcare. Across the four most recent quarters, ANTM averaged $59.00 in diluted EPS.

Company Profile

Elevance Health Inc. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Indianapolis, US. The company is led by CEO Gail Boudreaux. ANTM has traded publicly since 2001.

ANTM Financials

ANTM Latest News

ANTM Analyst Consensus

ANTM MoonshotScore

Common Questions About ANTM (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources